D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
SMMT holding history
Summit Therapeutics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SMMT overviewAll 13F holders of SMMTFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,243,556
- Value
- $18.1M
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,243,556 | $18.1M | <0.1% | −998,673−44.5% | Reduced | Holders |
| Q1 2026 | 2,242,229 | $42.5M | <0.1% | +1,826,945+439.9% | Added | Holders |
| Q4 2025 | 415,284 | $7.26M | <0.1% | +284,657+217.9% | Added | Holders |
| Q3 2025 | 130,627 | $2.70M | <0.1% | −6,818−5.0% | Reduced | Holders |
| Q2 2025 | 137,445 | $2.92M | <0.1% | +107,666+361.6% | Added | Holders |
| Q1 2025 | 29,779 | $574.4K | <0.1% | −6,242−17.3% | Reduced | Holders |
| Q4 2024 | 36,021 | $642.8K | <0.1% | −366,146−91.0% | Reduced | Holders |
| Q3 2024 | 402,167 | $8.81M | <0.1% | +372,467+1,254.1% | Added | Holders |
| Q2 2024 | 29,700 | $231.7K | <0.1% | +29,700 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −15,146−100.0% | Sold out | Holders |
| Q4 2021 | 15,146 | $41.0K | <0.1% | −8,004−34.6% | Reduced | Holders |
| Q3 2021 | 23,150 | $116.0K | <0.1% | +12,988+127.8% | Added | Holders |
| Q2 2021 | 10,162 | $76.0K | <0.1% | +10,162 | New | Holders |